---
title: "BeOne Medicines Ltd (6160) Gets a Buy from Nomura"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293988089.md"
description: "Nomura analyst maintained a Buy rating on BeOne Medicines Ltd on July 24 and set a price target of HK$270.74. The company’s shares closed yesterday at HK$199.20.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks BeOne Medicines Ltd has an analyst consensus of Strong Buy, with a price target consensus of HK$259.64."
datetime: "2026-07-28T00:35:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293988089.md)
  - [en](https://longbridge.com/en/news/293988089.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293988089.md)
---

# BeOne Medicines Ltd (6160) Gets a Buy from Nomura

Nomura analyst maintained a Buy rating on BeOne Medicines Ltd on July 24 and set a price target of HK$270.74. The company’s shares closed yesterday at HK$199.20.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

BeOne Medicines Ltd has an analyst consensus of Strong Buy, with a price target consensus of HK$259.64.

### Related Stocks

- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)

## Related News & Research

- [Bank of China Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)](https://longbridge.com/en/news/285667787.md)
- [BeOne Medicines Ltd (6160) Gets a Buy from CMBC International](https://longbridge.com/en/news/285886964.md)
- [Jefferies Reaffirms Their Buy Rating on Pricesmart (PSMT)](https://longbridge.com/en/news/295817325.md)
- [Citi Sticks to Its Sell Rating for MTR (MTRJF)](https://longbridge.com/en/news/295987682.md)
- [Mizuho Securities Reaffirms Their Buy Rating on JD (JD)](https://longbridge.com/en/news/295947678.md)